Back to Journals » Journal of Asthma and Allergy » Volume 12

Thunderstorm-triggered asthma: what we know so far

Authors Harun NS, Lachapelle P, Douglass J

Received 31 December 2018

Accepted for publication 14 March 2019

Published 6 May 2019 Volume 2019:12 Pages 101—108


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Amrita Dosanjh

Nur-Shirin Harun,1,2 Philippe Lachapelle,3,4 Jo Douglass2,3

1Department of Respiratory and Sleep Medicine, The Royal Melbourne Hospital, Melbourne, VIC, 3050, Australia; 2Lung Health Research Centre, The University of Melbourne, Melbourne, VIC, 3052, Australia; 3Department of Immunology and Allergy, The Royal Melbourne Hospital, Melbourne, VIC, 3050, Australia; 4Pulmonary Division, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, QC, Canada

Abstract: Thunderstorm-triggered asthma (TA) is the occurrence of acute asthma attacks immediately following a thunderstorm. Epidemics have occurred across the world during pollen season and have the capacity to rapidly inundate a health care service, resulting in potentially catastrophic outcomes for patients. TA occurs when specific meteorological and aerobiological factors combine to affect predisposed patients. Thunderstorm outflows can concentrate aeroallergens, most commonly grass pollen in TA, at ground level to release respirable allergenic particles after rupture by osmotic shock related to humidity and rainfall. Inhalation of high concentrations of these aeroallergens by sensitized individuals can induce early asthmatic responses which are followed by a late inflammatory phase. Other environmental factors such as rapid temperature change and agricultural practices contribute to the causation of TA. The most lethal TA event occurred in Melbourne, Australia, in 2016. Studies on the affected individuals found TA to be associated with allergic rhinitis, ryegrass pollen sensitization, pre-existing asthma, poor adherence to inhaled corticosteroid preventer therapy, hospital admission for asthma in the previous year and outdoor location at the time of the storm. Patients without a prior history of asthma were also affected. These factors are important in extending our understanding of the etiology of TA and associated clinical indicators as well as possible biomarkers which may aid in predicting those at risk and thus those who should be targeted in prevention campaigns. Education on the importance of recognizing asthma symptoms, adherence to asthma treatment and controlling seasonal allergic rhinitis is vital in preventing TA. Consideration of allergen immunotherapy in selected patients may also mitigate risk of future TA. Epidemic TA events are predicted to increase in frequency and severity with climate change, and identifying susceptible patients and preventing poor outcomes is a key research and public health policy priority.

Keywords: asthma, thunderstorm, rhinitis, ryegrass


Thunderstorm-triggered asthma (TA) is the occurrence of acute asthma attacks immediately following a thunderstorm.1 TA epidemics are uncommon and are believed to occur when specific meteorological and aerobiological conditions combine to affect predisposed patients. Symptoms such as breathlessness, cough or wheeze occur suddenly in such patients due to bronchospasm and often require emergency medical treatment via a general practitioner or emergency department (ED) presentation and/or hospitalization. Episodes occur typically during storms in pollen season across the world.2

The largest and most devastating epidemic of TA occurred in Melbourne, Australia, in November 2016 where more than 3,400 people sought emergency medical attention and 10 deaths were reported.36 The unprecedented scale and severity of the attack and the unexpected nature of the event saw emergency services rapidly overwhelmed.3,4 It demanded an urgent and thorough investigation into the phenomenon of TA via coronial inquiry and a rethink on the likely attributable factors and what we can do to prevent such tragic outcomes in the future.

Since the Melbourne 2016 event, there have been a number of publications that have furthered our understanding of TA. In the absence of randomized trial data, we rely on retrospective analyses for potential risk associations as well as data from some case-control studies. Further research using larger cohorts and longer-term studies are required.


Epidemics of TA have occurred throughout the world and are characterized by a rapid increase in emergency visits for asthma to general practices or hospital EDs following a storm, above what would normally be expected for that area.1,5 In Australia, community pharmacies can also be overwhelmed, likely due to the over-the-counter availability of short-acting β2-agonist (SABA) medications.3 These epidemics affect large numbers of people and can be potentially fatal, as the Melbourne 2016 epidemic uncovered.5

TA epidemics were first described over 30 years ago and have occurred in the UK, North America, Southern Europe and the Middle East during the late spring or early summer pollen seasons (Table 1).4,5 Most frequently however, events have occurred in Australia – all during the Spring season and most commonly in November – with at least six discrete events in Melbourne alone since 1984 and elsewhere including rural New South Wales and Canberra.35 Grass pollen is believed to have triggered all Australian events as well as the majority of events worldwide. Fungal spores and other types of pollen (such as olive) have been implicated in some of the events in the UK, Italy and Canada.4,7

Table 1 Previously reported thunderstorm-triggered asthma events

While TA epidemics are considered relatively uncommon, asthma exacerbations following thunderstorms are likely underreported. An observational study in the US analyzed more than 215,832 asthma ED presentations between 1993 and 2004 and reported an increased risk of emergency visits following a thunderstorm of 3%.8 A Canadian study found that risk was elevated up to 35% when only summer emergency visits were analyzed.9 Concomitant analysis on pollen or air pollution concentrations was not performed in these studies however. A separate study looking at seasonal variation in asthma admissions in Melbourne from 1991 to 2015 found peaks in hospital admission at the beginning of the school year, in the winter months and during peak pollen season. It suggested that TA could be a semi-regular seasonal occurrence that can go unrecognized and may be responsible for more of the total asthma burden of the disease than originally thought.10

Prior to the Melbourne 2016 event, deaths from TA were rare.5 However, TA events are predicted to increase in frequency and severity.2 In the scientific literature, description of epidemics of TA in various geographical areas of the world and climate change scenarios indicate there will be an increase in extremes of weather and intensity of heavy rainfall episodes, including thunderstorms, across the world.2,5 It is thus prudent to examine the contributing factors in at-risk regions specifically to identify important or interacting variables that may affect or lead to prevention of such events in the future.

Previous epidemiological studies have identified at-risk populations as those with diagnosed asthma (in particular, individuals with poorly controlled asthma and those not taking regular preventer medication), those with undiagnosed asthma and those with seasonal allergic rhinitis or ryegrass allergy.3,6,11,12


The most current evidence suggests that TA results from a complex interaction of environmental factors and individual susceptibility factors.6 TA events occur when a high concentration of aeroallergens (most commonly grass pollen and/or fungal spores) are concentrated at ground level by the thunderstorm outflow tract. Allergens can then reach the lower airways of sensitized individuals by being broken into smaller particles due to osmotic shock related to rainfall and humidity.13,14

The role of ryegrass pollen in TA has been established in the seminal papers by Suphioglu, Knox and colleagues where starchy granules derived from ryegrass pollen particles, observed in pollen trap specimens from a recent TA event, were re-created in the laboratory by soaking pollen particles in water.15,16 Intact grass pollen grains (35–40 μm) are usually too large to be respirable to the lower airways. Ruptured pollen grains, however, can release up to 700 starch granules smaller than the maximum 5 μm particle size required to reach the lower airways. These starch particles were demonstrated to contain major ryegrass allergens and were subsequently used to induce striking asthma following bronchial challenge in ryegrass sensitized patients.1517 The role of ryegrass is further supported by the presence of ryegrass-specific IgE being an almost universal finding in TA sufferers during the Melbourne 2016 event.6

The role of molds causing TA events is more contentious. It is evident that mold particles are a trigger for hospitalizations in some environments and that mold spores of many species are frequently detected in pollen traps but are not routinely reported.18 While increased prevalence of allergic sensitization to molds has been reported in TA sufferers,19 this has not been uniformly found.13 However, fungi can stimulate the innate immune system independently of IgE to cause inflammation, suggesting an alternative immunological pathway to airway inflammation that has yet to be confirmed in TA.20

The rapid onset and offset of symptoms in those affected during TA events have been attributed to allergen-induced early asthmatic responses which are followed by the late inflammatory phase. As classically described in allergic asthma, pollen particles can initiate mast cell degranulation and bronchoconstriction within a few minutes.15 In predisposed individuals, exposure to ryegrass antigens, for example, can initiate the sensitization process by activating antigen-presenting cells (including dendritic cells and macrophages), Th2 lymphocytes and trigger heavy-chain class switching in B lymphocytes in favor of IgE production. On allergen re-exposure, cross-linking of IgE to the high-affinity receptor (FcεRI) complex on the surface of mast cells and basophils in these IgE-sensitized individuals initiate the IgE early response. The release of histamine, tryptase, leukotriene and prostaglandin all contribute to mucus secretion, mucosal edema and airways smooth muscle contraction.21

The early asthmatic response depends on the degree of sensitization to an allergen, the magnitude of the untreated airway hyperresponsiveness and the dose of allergen inhaled.22 The late asthmatic response follows with Th2 lymphocyte activation, type 2 cytokine formation (IL4, IL-5, IL-9 and IL-a3) and an influx of inflammatory cells including eosinophils. This later response is responsive to corticosteroid treatment.23

IgE responses in murine models showed that exposure to pollen grains or starch particles less than 5 μm resulted in higher eosinophil, lymphocyte and pro-allergy cytokine levels in the lung, linking these inflammatory responses to asthma-related allergic symptoms.24 Interestingly, after repetitive high-dose and short-interval bronchial allergen challenges, patients who developed late response inflammation were at more risk of developing severe bronchospasm on subsequent allergen challenge.25 This has implications on the future risk and prevention of TA in patients with a prior history of asthma or TA.

These early and late asthmatic responses were also observed in the 2016 Melbourne TA epidemic. Some patients had acute bronchospasm necessitating acute resuscitation in the minutes following the thunderstorm, whilst others self-medicated with short-acting bronchodilators without seeking medical advice, consistent with rapid resolution of bronchospasm in the early asthmatic response. Asthma presentations were also higher in the 24 hrs after the event, with a second peak for ambulance calls 4 hrs after the initial event, suggesting a late response after unsuccessful treatment with bronchodilator alone.3

Contributing factors

Environmental factors

Why TA occurs in some years and not others is incompletely understood. The requirement for both thunderstorm activity to co-exist with high levels of airborne aeroallergens is already known.13 In Melbourne, high grass pollen seasons have also been shown to correlate well with high winter rainfall.5 In vitro studies show that a cycle of humidifying, wetting and drying of flowering grasses, followed by wind disturbance, releases grass pollen allergen as respirable aerosols directly from the flower.26 Concordantly, ruptured ryegrass was increased by 147% after the passage of the storm in the Melbourne 2016 event.3

Although many TA events in Melbourne follow wet winters, this does not explain all events. In addition, not everyone with grass pollen allergy or allergic rhinitis is at risk of asthma during thunderstorm-triggered asthma epidemics and asthma epidemics can similarly occur without thunderstorms.5 Other environmental factors, such as sudden cold, have also been postulated in TA.14,27 The 2016 Melbourne event saw a rapid and dramatic fall in temperature and a rise in relative humidity levels as the storm front passed. A similar pattern was seen during the 1994 London TA epidemic.27 Total rainfall was minimal, however, during the Melbourne event.3

The impact of air pollution has been questioned but has not yet been conclusively proven to contribute to causation of TA. The Environment Protection Authority Victoria, measuring fine particle air pollutants PM2.5 and PM10 in Melbourne in 2016, found no increase in PM2.5 but elevated levels of PM10 (particles ≤10 μm) after the storm outflow passage. However, elevated PM10 levels are a common finding during high wind events and have not been shown to correlate with previously identified TA days.3

Air pollution can increase airway hyperresponsiveness to aeroallergens in atopic individuals.28 It has been postulated via experimental models that by attaching to the surface of pollen grains, pollutants could modify the allergenic potential of these particles, induce airway inflammation and hence permeability in order to overcome the mucosal barrier of the lung and enhance IgE-mediated responses to aeroallergens. Furthermore, airway mucosal damage and impaired mucociliary clearance due to air pollution has been thought to facilitate the access of inhaled allergens to cells of the immune system and promote airway sensitization.28 Type 2 cytokines are also further increased when pollen is combined with diesel exhaust particles.29

Agricultural activity has also been thought to contribute to TA by releasing high levels of fungal spores and grass pollens. Ryegrass, with widespread pastures to the north of Melbourne, have clearly been implicated in the Australian epidemics. Wheat harvesting has been thought to be implicated in other parts of the world where fungal spores are considered the predominant aeroallergen.5

The role of aeroallergens

In the Australian sub-continental region, most patients who suffer from seasonal allergies are sensitized to ryegrass.30 As we know, high levels of aeroallergens in the air are required for TA to occur. Both the Melbourne 2016 and other Australian events occurred on high grass pollen days and ryegrass was implicated. Ryegrass is abundantly grown in Australia and the peak of its pollen season is November which coincides with periods when TA is most likely to occur.3 Other outbreaks around the world have shown fungal spores (such as Alternaria, Cladosporium and Didymella species) to be implicated.7

The effect of aeroallergens on an individual depends on their exposure and their allergic sensitization status to that aeroallergen. Prior studies have found that those not allergic to the triggering allergen source and those who stayed indoors seemed to be protected from risk.2,12 Thus, there may be some evidence that remaining indoors during and after a thunderstorm is protective. Furthermore, IgE-mediated responses via skin prick testing or measurement of serum-specific IgE concentrations may give some insight into the degree of sensitization of an individual to an aeroallergen.31

Individual susceptibility factors

Vulnerability to TA appears to be linked to an individual’s allergic sensitivity and disease status. Individuals need to be either 1) sensitized to the triggering allergen, 2) suffer from allergic rhinitis (hay fever) with or without asthma or 3) be exposed to the open air and not be on preventative asthma treatment.3 There is no clear common allergen globally; however, in the Australian epidemics, there has been almost universal allergic sensitization to ryegrass.12

This is also supported by the vulnerability factors found in the individuals who were followed-up after the Melbourne 2016 epidemic. In these individuals, being affected by TA was associated with: allergic rhinitis, ryegrass pollen sensitization, pre-existing asthma, poor adherence to inhaled corticosteroid (ICS) preventer, hospital admission for asthma in the previous year and outdoor location at the time of the storm.6

Although most patients in the cohort did not have doctor-diagnosed asthma, all of the 35 critically ill patients admitted to ICU did have a previous diagnosis of asthma, suggesting more severe TA in known asthmatics. Of these, 66% were not on preventer medications, implicating issues with sub-optimal control of asthma and treatment adherence as contributing factors.6,22,32

The ICU patients with TA during the event had a very high mortality (14%) compared to non-TA asthma patients presenting at other times in that year (1%).32 TA patients admitted to the ICU were also more likely to be male (63%). This is in contrast to the largely female predominance of those affected by non-epidemic adult asthma, previously attributed to hormonal differences in gender.3234

There was also a novel finding of ethnic predominance of Asian ethnicity in affected patients during the Melbourne 2016 event.6 In those of Asian ethnicity, those born in Australia had a higher risk of TA than those born overseas. Patients of Asian ethnicity were also over-represented in the ICU admissions and it is interesting that previous studies also found increased prevalence of non-epidemic asthma, hay fever and allergic rhinitis amongst Asian migrants to Australia compared with non-migrant populations.6,11,32,35 This may imply further genetic and environmental interactions which are currently poorly understood.

Overall, these findings suggest that not only do factors of ethnicity and gender predispose patients to TA beyond differences in asthma education and management alone, but that TA patients appear to represent a population that is different to those with non-epidemic asthma. This appears to be supported by literature during the London 1994 TA epidemic which suggested that TA patients appear to be sensitive to different environmental stimuli with non-epidemic asthma being related to air pollution and lightning strikes, for example, which was not found with TA.27

Another concerning statistic in the Melbourne 2016 cohort is that more than 50% of the individuals did not have a previous diagnosis of asthma although a large proportion (26%) had symptoms suggestive of latent asthma.11 This has important implications in prevention of TA by especially targeting those with symptoms of asthma to optimize their asthma control prior to pollen season. This would include advice regarding adherence to preventer treatment and carrying reliever medication in the event of an unexpected asthma attack.

However, this finding also poses a problem in understanding how to best identify those at risk with neither a prior history of asthma nor symptoms of asthma. This unexpectedly large proportion of those experiencing asthma for the first time during a TA epidemic makes predicting those at risk difficult and, currently, there is no evidence-based prevention advice for this group of patients.

It is interesting, however, that 90–100% of those affected with acute breathing difficulties during thunderstorm events both locally and internationally had a history of allergic rhinitis. Thus, targeting this group may be more useful on a population level. However, 15% of Australians suffer from allergic disease and up to two-thirds of those have grass pollen allergy, making the problem widespread and difficult to predict.5

The link between allergic rhinitis and asthma is an important one nonetheless. Most patients with asthma have rhinitis (both allergic and non-allergic) and general recommendations are to treat both conditions where they co-exist.6 The presence of rhinitis is associated with asthma and increases the risk of emergency visits and hospitalization due to asthma.36,37 Interestingly, it appears that TA is primarily an allergic, IgE-mediated airways response in atopic subjects to trigger factors (such as grass pollens) and subjects with non-allergic asthma do not appear to be involved in TA epidemics.2 Intranasal corticosteroid sprays, antihistamines, and in some patients, specific allergen immunotherapy directed at controlling rhinitis symptoms are strongly encouraged and may mitigate the risk of TA in these patients.23,36,37

Ryegrass pollen sensitization was found to be universal in those retrospectively examined in the Melbourne 2016 epidemic and previous studies have found that allergen-specific IgE may be a reliable biomarker for allergen-related symptoms.12,38,39 The role of biomarkers such as serum-specific IgE and measurement of airway inflammation via exhaled nitric oxide to characterize those at risk of future TA events are uncertain however.


Education campaigns aimed at understanding good asthma control and adherence to preventer medications may protect asthmatic patients from experiencing exacerbations during TA epidemics. Adequate control of seasonal rhinitis and advice to seek medical attention if symptoms escalate or symptoms indicative of asthma develop (wheeze, cough, breathlessness) should be promoted in public health messaging.

Predicting patients who will experience symptoms of asthma for the first time or which seasonal rhinitis patients are at risk of TA is difficult. Immunological and genetic biomarkers may be useful and are currently being explored, as are studies investigating whether treating high-risk allergic rhinitis patients with asthma treatments or with allergen immunotherapy will prevent progression to asthma.30,38,39

Development of pollen counters and applications in conjunction with weather forecasting may form the beginnings of an alert system for TA to health services and high-risk individuals. Public health warnings need to be delivered with a timely, targeted and evidence-based approach.1

The factors that contribute to rapid changes in weather and the ability to understand whether these can be reliably predicted over time remain a priority. The ability to accurately predict thunderstorms and a TA epidemic based on the known requisite factors for such an event would inform a public health warning system. This has been difficult to develop however as prediction models that would be required to integrate multiple information sources are complex and difficult to enact on a large scale. At present, the high false alarm rate for such a warning system would be deemed unacceptable.6 Nevertheless, collaboration between health services, governmental departments, biologists, meteorologists, epidemiologists and the community and more effective communication methods between these groups is required.

Perhaps the bigger issue, however, is that of sub-optimally controlled asthma in the community at large. This was uncovered with devastating effect during the Melbourne 2016 epidemic. In Australia, the prevalence of asthma in children is among the highest in the world (up to 20%) and in 2015, 421 people died of asthma overall.4

The risks of even mild asthma can be underestimated by both clinician and patient. Over-reliance on SABA reliever medication and poor adherence to ICS, despite their proven efficacy, can increase risk for exacerbations. Large randomized controlled studies assessing the use of as-required ICS/long-acting β2-agonist (LABA) combinations in mild asthma as an alternative to regular low-dose ICS showed prevention of exacerbations and loss of lung function and reduced glucocorticoid exposure however was less effective at symptom control. Nevertheless, as-required ICS/LABA treatment may be a more pragmatic way to address the issues of poor adherence to regular ICS.40,41

TA is not frequent and not the main trigger for allergic respiratory disease overall but can teach us important lessons on the importance of good asthma control.2,6,1012 Government campaigns and public health messaging need to focus on this. General practitioner and ED pathways for asthma management, including provision of asthma action plans, should be optimized as well as emergency response pathways during a TA epidemic.


TA is a sudden and potentially deadly phenomenon that has the capability to rapidly inundate emergency resources and relies on a complex interaction of environmental and individual patient susceptibility factors. As TA events are predicted to increase in frequency, the impact of climate change, changing agricultural practices and air pollution needs careful consideration. Further research on how to predict these events is vital and will require collaboration between health services, governmental departments and the community.

An early warning system based on environmental factors to alert emergency services and allow communication to at-risk individuals is necessary; however, it is difficult to implement given an unacceptably high false alarm rate currently.

The further challenge is to identify those individuals at risk and target prevention strategies efficiently and effectively. Those with known asthma should have treatment optimized and be educated on adherence to preventer treatment. Seasonal rhinitis patients should be evaluated for asthma symptoms also and have rhinitis optimized via nasal corticosteroids. Consideration of grass pollen immunotherapy may offer opportunities to treat both allergic rhinitis and asthma in these circumstances.

Finally, further research into understanding the pathophysiology behind the effects of TA in susceptible individuals is paramount. Development of potential biomarkers that would signal an at-risk patient would mean these individuals could be pre-emptively treated, thus mitigating risk for future TA attacks in the inevitable event of a repeat TA epidemic.


Professor Jo Douglass reports personal fees from Novartis, GSK, and Astra Zeneca; received funds for investigating in commercially funded trials for GSK, Astra Zeneca,  and Sanofi-Aventis; received royalties from Health Press from the publication of Fast Facts, during the conduct of the study. Also received funds outside the submitted work from BioCryst and Grifols for investigating in a commercially sponsored clinical trial; and funds from Novartis for intiatiating a trial at the The Royal Melbourne Hospital. The authors report no other conflicts of interest in this work. 


1. Lindstrom SJ, Silver JD, Sutherland MF, et al. Thunderstorm asthma outbreak of November 2016: a natural disaster requiring planning. Med J Aust. 2017;207:235–237.

2. D’Amato G, Holgate ST, Pawankar R, et al. Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization. World Allergy Organ J. 2015;8:73. doi:10.1186/s40413-015-0073-0

3. The Chief Health Officer. The November 2016 Victoria Epidemic Thunderstorm Asthma Event: An Assessment of the Health Impacts. Australia: Department of Health and Human Services, Victorian State Government;2017.

4. Andrew E, Nehme Z, Bernard S, et al. Stormy weather: a retrospective analysis of demand for emergency medical services during epidemic thunderstorm asthma. BMJ. 2017;359:j5636. doi:10.1136/bmj.j5636

5. Queensland University of Technology. Literature Review on Thunderstorm Asthma and Its Implications for Public Health Advice. Australia: Department of Health and Human Services, Victorian State Government;2017.

6. Thien F, Beggs PJ, Csutoros D, et al. The Melbourne thunderstorm asthma event 2016: an investigation of environmental triggers, effects on health services and patient risk factors. Lancet Planet Health. 2018;2:255–263. doi:10.1016/S2542-5196(18)30120-7

7. Pulimood T, Corden J, Bryden C, Sharples L, Nasser SM. Epidemic asthma and the role of the fungal mold Alternaria alternate. J Allergy Clin Immunol. 2007;120:610–617. doi:10.1016/j.jaci.2007.04.045

8. Grundstein A, Sarnat SE, Klein M, et al. Thunderstorm-associated asthma in Atlanta, Georgia. Thorax. 2008;63:659–660. doi:10.1136/thx.2007.092882

9. Villeneuve PJ, Leech J, Bourque D. Frequency of emergency room visits for childhood asthma in Ottawa, Canada: the role of weather. Int J Biometeorol. 2005;50:48–56. doi:10.1007/s00484-005-0262-6

10. Silver JD, Sutherland MF, Johnston FH, et al. Seasonal asthma in Melbourne, Australia, and some observations on the occurrence of thunderstorm asthma and its predictability. PLoS One. 2018;13:e0194929. doi:10.1371/journal.pone.0194929

11. Hew M, Lee J, Susanto NH, et al. The 2016 Melbourne thunderstorm asthma epidemic: risk factors for severe attacks requiring hospital admission. Allergy. 2018;00:1–9.

12. Lee J, Kronborg C, O’Hehir RE, Hew M. Who’s at risk of thunderstorm asthma? The ryegrass pollen trifecta and lessons learnt from the Melbourne thunderstorm epidemic. Respir Med. 2018;132:146–148. doi:10.1016/j.rmed.2017.10.012

13. Marks G, Bush R. It’s blowing in the wind: new insights into thunderstorm-related asthma. J Allergy Clin Immunol. 2007;120:530–532. doi:10.1016/j.jaci.2007.07.012

14. D’Amato G, Annesi-Maesano I, Vaghi A, et al. How do storms affect asthma? Curr Allergy Asthma Rep. 2018;18:24. doi:10.1007/s11882-018-0775-9

15. Suphioglu C, Singh MB, Taylor P, et al. Mechanisms of grass-pollen-induced asthma. Lancet. 1992;339:569–572.

16. Knox RB. Grass pollen, thunderstorms and asthma. Clin Exp Allergy. 1993;23:354–359.

17. Yeh HC, Schum GM. Models of human lung airways and their application to inhaled particle deposition. Bull Math Biol. 1980;43:461–480. doi:10.1007/BF02460796

18. Tham R, Vicendese D, Dharmage SC, et al. Associations between outdoor fungal spores and childhood and adolescent asthma hospitalizations. J Allergy Clin Immunol. 2017;139:1140–1147. doi:10.1016/j.jaci.2016.06.046

19. Atkinson RW, Strachan DP, Anderson HR, Hajat S, Emberlin J. Temporal associations between daily counts of fungal spores and asthma exacerbations. Occup Environ Med. 2006;63:580–590. doi:10.1136/oem.2005.024448

20. Bartemes KR, Kita H. Innate and adaptive immune responses to fungi in the airway. J Allergy Clin Immunol. 2018;142:353–363. doi:10.1016/j.jaci.2018.06.015

21. Eifan AO, Durham SR. Pathogenesis of rhinitis. Clin Exp Allergy. 2016;46(9):1139–1151. doi:10.1111/cea.12780

22. Cockcroft DW. Epidemic thunderstorm asthma. Lancet Planet Health. 2018;2:e236. doi:10.1016/S2542-5196(18)30123-2

23. Cockcroft DW, Davis BE, Blais CM. Thunderstorm asthma: an allergen-induced early asthmatic response. Ann Allergy Asthma Immunol. 2018;120:120–123. doi:10.1016/j.anai.2017.12.002

24. Abou Chakra O, Rogerieux F, Poncet P, et al. Ability of pollen cytoplasmic granules to induce biased allergic responses in a rat model. Int Arch Allergy Immunol. 2011;154(2):128–136. doi:10.1159/000320227

25. Schulze J, Voss S, Zissler U, Rose MA, Zielen S, Schubert R. Airway responses and inflammation in subjects with asthma after four days of repeated high-single-dose allergen challenge. Respir Res. 2012;13:78. doi:10.1186/1465-9921-13-78

26. Taylor PE, Flagan RC, Valenta R, Glovsky MM. Release of allergens as respirable aerosols: a link between grass pollen and asthma. J Allergy Clin Immunol. 2002;109(1):51–56.

27. Celenza A, Fothergill J, Kuprek E, Shaw RJ. Thunderstorm asthma: a detailed analysis of environmental factors. BMJ. 1996;312:604. doi:10.1136/bmj.312.7031.604

28. D’Amato G, Liccardi G, D’Amato M, Holgate S. Environmental risk factors and allergic bronchial asthma. Clin Exp Allergy. 2005;35:1113–1124. doi:10.1111/j.1365-2222.2005.02328.x

29. Diaz-Sanchez D, Tsien A, Fleming J, Saxon A. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J Immunol. 1997;158(5):2406–2413.

30. O’Hehir RE, Varese NP, Deckert K, et al. Epidemic thunderstorm asthma protection with five-grass pollen tablet sublingual immunotherapy: a clinical trial. Ajrccm. 2018;198:126–128.

31. Davies JM, Thien F, Hew M. Thunderstorm asthma: controlling (deadly) grass pollen allergy. BMJ. 2018;360:k432. doi:10.1136/bmj.k432

32. Darvall JN, Durie M, Pilcher D. Intensive care implications of epidemic thunderstorm asthma. Cri Care Resusc. 2018;20:294–303.

33. Zien JG, Erzurum SC. Asthma is different in women. Curr Allergy Asthma Rep. 2015;15:28. doi:10.1007/s11882-015-0528-y

34. Almqvist C, Worm M, Leynaert B. Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy. 2008;63:47–57. doi:10.1111/j.1398-9995.2007.01524.x

35. Leung R. Asthma, allergy and atopy in Asian immigrants in Melbourne. Med J Aust. 1994;161:418–425.

36. Lohia S, Schlosser RJ, Soler SM. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis. Allergy. 2013;68:569–579. doi:10.1111/all.12124

37. Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol. 2002;109:636–642.

38. Corsico AG, De Amici M, Ronzoni V, et al. Allergen-specific immunoglobulin E and allergic rhinitis severity. Allergy Rhinol. 2017;8:e1–e4. doi:10.2500/ar.2017.8.0187

39. Olivieri M, Heinrich J, Schlunssen V, et al. The risk of respiratory symptoms on allergen exposure increases with increasing specific IgE levels. Allergy. 2016;71:859–869. doi:10.1111/all.12841

40. O’Byrne PM, Fitzgerald JM, Bateman ED, et al. Inhaled combined budesonide-formoterol as needed in mild asthma. N Engl J Med. 2018;378:1865–1876. doi:10.1056/NEJMoa1715274

41. Bateman ED, Reddel HK, O’Byrne PM, et al. As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. N Engl J Med. 2018;378:1877–1887. doi:10.1056/NEJMoa1715275

42. Packe GE, Ayres JG. Asthma outbreak during a thunderstorm. Lancet. 1985;2:199–204.

43. Egan P. Weather or not. Med J Aust. 1985;142:330.

44. Alderman PM, Sloan JP, Basran GS. Asthma and thunderstorms. Arch Emerg Med. 1986;3:260–262.

45. Bellomo R, Gigliotti P, Treloar A, et al. Two consecutive thunderstorm associated epidemics of asthma in the city of Melbourne. The possible role of rye grass pollen. Med J Aust. 1992;156:834–837.

46. Waters J, Corbett S, Gibson P, Hensley M, Wlodarczyk J. Epidemic asthma surveillance in the New England Region 1990–1992. NSW Public Health Bull. 1993;4:100–101. doi:10.1071/NB93049

47. Davidson AC, Emberlin J, Cook AD, Venables KM. Thames Regions Accident and Emergency Trainees Association. A major outbreak of asthma associated with a thunderstorm: experience of accident and emergency departments and patients’ characteristics. BMJ. 1996;312:601–604.

48. Higham J, Venables K, Kupek E, Bajekal M. Asthma and thunderstorms: description of an epidemic in general practice in Britain using data from a doctors’ deputising service in the UK. J Epidemiol Community Health. 1997;51:233–238.

49. Girgis ST, Marks GB, Downs SH, Kolbe A, Car GN, Paton R. Thunderstorm-associated asthma in an inland town in south-eastern Australia. Who Is at Risk? Eur Respir J. 2000;16:3–8.

50. Wark PAB, Simpson J, Hensley MJ, Gibson PG. Airway inflammation in thunderstorm asthma. Clin Exp Allergy. 2002;32:1750–1756.

51. Wardman AED, Stefani D, MacDonald JC. Thunderstorm-associated asthma or shortness of breath epidemic: a Canadian case report. Can Respir J. 2002;9:267–270. doi:10.1155/2002/728257

52. Al-Rubaish AM. Thunderstorm-associated bronchial asthma: a forgotten but very present epidemic. J Family Community Med. 2007;14:47–51.

53. Erbas B, Akram M, Dharmage SC, et al. The role of seasonal grass pollen on childhood asthma emergency department presentations. Clin Exp Allergy. 2012;42:799–805. doi:10.1111/j.1365-2222.2012.03995.x

54. D’Amato G, Cecchi L, Liccardi G. Thunderstorm-related asthma: not only grass pollen and spores. J Allergy Clin Immunol. 2008;121:537–538. doi:10.1016/j.jaci.2007.10.046

55. Levy ML, Bryden C. Thunderstorm asthma. Brit J Primary Care Nurs. 2007;1:69–71.

56. Losappio L, Heffler E, Contento F, Cannito C, Rolla G. Thunderstorm-related asthma epidemic owing to Olea Europaea pollen sensitization. Allergy. 2011;66:1510–1511. doi:10.1111/j.1398-9995.2011.02699.x

57. Howden ML, McDonald CF, Sutherland MF. Thunderstorm asthma – a timely reminder. Med J Aust. 2011;195:512–513.

58. Elliot AJ, Hughes HE, Hughes TC, et al. The impact of thunderstorm asthma on emergency department attendances across London during July 2013. Emerg Med J. 2014;31:675–678. doi:10.1136/emermed-2013-203122

59. Forouzan A, Masoumi K, Haddadzadeh Shoushtari M, et al. An overview of thunderstorm-associated asthma outbreak in southwest of Iran. J Environ Public Health. 2014;2014:504017. doi:10.1155/2014/504017

60. Review of Response to the Thunderstorm Asthma Event of 21–22 November 2016. Inspector-General for Emergency Management;February 2017. Available from: Accessed April 12, 2019.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]